{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:12Z","timestamp":1790753832918,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:00:00Z","timestamp":1566950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The <jats:italic>\u03b2-catenin<\/jats:italic> mutation is frequently observed in hepatoblastoma (HB), but the underlying mechanism by which Wnt\/\u03b2-catenin signaling induces HB tumor formation is unknown. Here we show that expression of growth regulation by estrogen in breast cancer 1 (GREB1) depends on Wnt\/\u03b2-catenin signaling in HB patients. GREB1 is localized to the nucleus where it binds Smad2\/3 in a competitive manner with p300 and inhibits TGF\u03b2 signaling, thereby promoting HepG2 HB cell proliferation. Forced expression of \u03b2-catenin, YAP, and c-Met induces HB-like mouse liver tumor (BYM mice), with an increase in <jats:italic>GREB1<\/jats:italic> expression and HB markers. Depletion of GREB1 strongly suppresses marker gene expression and HB-like liver tumorigenesis, and instead enhances TGF\u03b2 signaling in BYM mice. Furthermore, antisense oligonucleotides for GREB1 suppress the formation of HepG2 cell-induced tumors and HB-like tumors in vivo. We propose that GREB1 is a target molecule of Wnt\/\u03b2-catenin signaling and required for HB progression.<\/jats:p>","DOI":"10.1038\/s41467-019-11533-x","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T10:03:18Z","timestamp":1566986598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGF\u03b2 signaling"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1804-264X","authenticated-orcid":false,"given":"Shinji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-3958","authenticated-orcid":false,"given":"Taku","family":"Yamamichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3767-428X","authenticated-orcid":false,"given":"Koei","family":"Shinzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuuya","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-1324","authenticated-orcid":false,"given":"Takahiro","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-6812","authenticated-orcid":false,"given":"Satoshi","family":"Obika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-9522","authenticated-orcid":false,"given":"Akira","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,28]]},"reference":[{"key":"11533_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999 (2017).","journal-title":"Cell"},{"key":"11533_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-386035-4.00002-1","volume":"291","author":"A Kikuchi","year":"2011","unstructured":"Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. New insights into the mechanism of wnt signaling pathway activation. Int. Rev. Cell Mol. Biol. 291, 21\u201371 (2011).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"11533_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gde.2006.12.007","volume":"17","author":"P Polakis","year":"2007","unstructured":"Polakis, P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17, 45\u201351 (2007).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"11533_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.onc.1209824","volume":"26","author":"J Zucman-Rossi","year":"2007","unstructured":"Zucman-Rossi, J. et al. Differential effects of inactivated Axin1 and activated \u03b2-catenin mutations in human hepatocellular carcinomas. Oncogene 26, 774\u2013780 (2007).","journal-title":"Oncogene"},{"key":"11533_CR5","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch, A. et al. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the \u03b2-catenin gene. Cancer Res. 59, 269\u2013273 (1999).","journal-title":"Cancer Res."},{"key":"11533_CR6","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.1542\/peds.2015-0224","volume":"136","author":"M Tulla","year":"2015","unstructured":"Tulla, M. et al. Incidence, trends, and survival of children with embryonal tumors. Pediatrics 136, e623\u2013e632 (2015).","journal-title":"Pediatrics"},{"key":"11533_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/1097-0142(19890901)64:5<1082::AID-CNCR2820640520>3.0.CO;2-G","volume":"64","author":"JE Haas","year":"1989","unstructured":"Haas, J. E. et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 64, 1082\u20131095 (1989).","journal-title":"Cancer"},{"key":"11533_CR8","first-page":"6367","volume":"60","author":"MG Ghosh","year":"2000","unstructured":"Ghosh, M. G., Thompson, D. A. & Weigel, R. J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60, 6367\u20136375 (2000).","journal-title":"Cancer Res."},{"key":"11533_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.celrep.2013.01.010","volume":"3","author":"H Mohammed","year":"2013","unstructured":"Mohammed, H. et al. Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep. 3, 342\u2013349 (2013).","journal-title":"Cell Rep."},{"key":"11533_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10549-005-1483-4","volume":"92","author":"JM Rae","year":"2005","unstructured":"Rae, J. M. et al. GREB 1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat. 92, 141\u2013149 (2005).","journal-title":"Breast Cancer Res. Treat."},{"key":"11533_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/pros.20403","volume":"66","author":"JM Rae","year":"2006","unstructured":"Rae, J. M. et al. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 66, 886\u2013894 (2006).","journal-title":"Prostate"},{"key":"11533_CR12","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada, D., Cheung, S. W., Finegold, M. J. & Knowles, B. B. Hep G2 is a hepatoblastoma-derived cell line. Hum. Pathol. 40, 1512\u20131515 (2009).","journal-title":"Hum. Pathol."},{"key":"11533_CR13","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","volume":"95","author":"A de La Coste","year":"1998","unstructured":"de La Coste, A. et al. Somatic mutations of the \u03b2-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 95, 8847\u20138851 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11533_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin, P. et al. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65, 104\u2013121 (2017).","journal-title":"Hepatology"},{"key":"11533_CR15","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1593\/neo.07469","volume":"9","author":"G Zeng","year":"2007","unstructured":"Zeng, G., Apte, U., Cieply, B., Singh, S. & Monga, S. P. siRNA-mediated \u03b2-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 9, 951\u2013959 (2007).","journal-title":"Neoplasia"},{"key":"11533_CR16","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1242\/dev.030338","volume":"136","author":"A Moustakas","year":"2009","unstructured":"Moustakas, A. & Heldin, C. H. The regulation of TGF\u03b2 signal transduction. Development 136, 3699\u20133714 (2009).","journal-title":"Development"},{"key":"11533_CR17","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1242\/dev.091769","volume":"142","author":"S Pauklin","year":"2015","unstructured":"Pauklin, S. & Vallier, L. Activin\/Nodal signalling in stem cells. Development 142, 607\u2013619 (2015).","journal-title":"Development"},{"key":"11533_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc.2016.41","volume":"16","author":"F Liu","year":"2016","unstructured":"Liu, F., Wang, L., Perna, F. & Nimer, S. D. Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape. Nat. Rev. Cancer 16, 359\u2013372 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"11533_CR19","doi-asserted-by":"publisher","first-page":"22865","DOI":"10.1074\/jbc.273.36.22865","volume":"273","author":"C Pouponnot","year":"1998","unstructured":"Pouponnot, C., Jayaraman, L. & Massague, J. Physical and functional interaction of SMADs and p300\/CBP. J. Biol. Chem. 273, 22865\u201322868 (1998).","journal-title":"J. Biol. Chem."},{"key":"11533_CR20","doi-asserted-by":"publisher","first-page":"970346","DOI":"10.1155\/2014\/970346","volume":"2014","author":"N Sakata","year":"2014","unstructured":"Sakata, N. et al. TGF-\u03b2 Signaling Cooperates with AT Motif-Binding Factor-1 for Repression of the \u03b1 -Fetoprotein Promoter. J. Signal Transduct. 2014, 970346 (2014).","journal-title":"J. Signal Transduct."},{"key":"11533_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/excr.1999.4624","volume":"252","author":"A Sanchez","year":"1999","unstructured":"Sanchez, A. et al. Apoptotic response to TGF-\u03b2 in fetal hepatocytes depends upon their state of differentiation. Exp. Cell Res. 252, 281\u2013291 (1999).","journal-title":"Exp. Cell Res."},{"key":"11533_CR22","doi-asserted-by":"publisher","first-page":"14771","DOI":"10.1073\/pnas.0706578104","volume":"104","author":"AD Tward","year":"2007","unstructured":"Tward, A. D. et al. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc. Natl Acad. Sci. USA 104, 14771\u201314776 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11533_CR23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen, X. & Calvisi, D. F. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am. J. Pathol. 184, 912\u2013923 (2014).","journal-title":"Am. J. Pathol."},{"key":"11533_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3727\/105221616X693639","volume":"17","author":"D Bell","year":"2017","unstructured":"Bell, D., Ranganathan, S., Tao, J. & Monga, S. P. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt\/\u03b2-Catenin Perspective. Gene Expr. 17, 141\u2013154 (2017).","journal-title":"Gene Expr."},{"key":"11533_CR25","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao, J. et al. Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147, 690\u2013701 (2014).","journal-title":"Gastroenterology"},{"key":"11533_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1756-9966-30-96","volume":"30","author":"R Purcell","year":"2011","unstructured":"Purcell, R. et al. HGF\/c-Met related activation of \u03b2-catenin in hepatoblastoma. J. Exp. Clin. Cancer Res. 30, 96 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"11533_CR27","doi-asserted-by":"publisher","first-page":"352ra108","DOI":"10.1126\/scitranslmed.aaf2304","volume":"8","author":"F Fan","year":"2016","unstructured":"Fan, F. et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci. Transl. Med. 8, 352ra108 (2016).","journal-title":"Sci. Transl. Med."},{"key":"11533_CR28","first-page":"2064","volume":"62","author":"SP Monga","year":"2002","unstructured":"Monga, S. P. et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of \u03b2-catenin after Met-\u03b2-catenin dissociation in hepatocytes. Cancer Res. 62, 2064\u20132071 (2002).","journal-title":"Cancer Res."},{"key":"11533_CR29","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1016\/j.yexcr.2006.08.003","volume":"312","author":"G Zeng","year":"2006","unstructured":"Zeng, G., Apte, U., Micsenyi, A., Bell, A. & Monga, S. P. Tyrosine residues 654 and 670 in \u03b2-catenin are crucial in regulation of Met-\u03b2-catenin interactions. Exp. Cell Res. 312, 3620\u20133630 (2006).","journal-title":"Exp. Cell Res."},{"key":"11533_CR30","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1002\/cbic.201200506","volume":"13","author":"A Yahara","year":"2012","unstructured":"Yahara, A. et al. Amido-bridged nucleic acids (AmNAs): synthesis, duplex stability, nuclease resistance, and in vitro antisense potency. Chembiochem 13, 2513\u20132516 (2012).","journal-title":"Chembiochem"},{"key":"11533_CR31","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1210\/me.2007-0082","volume":"21","author":"J Sun","year":"2007","unstructured":"Sun, J., Nawaz, Z. & Slingerland, J. M. Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol. Endocrinol. 21, 2651\u20132662 (2007).","journal-title":"Mol. Endocrinol."},{"key":"11533_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/0008-5472.CAN-06-2559","volume":"67","author":"E Labbe","year":"2007","unstructured":"Labbe, E. et al. Transcriptional cooperation between the transforming growth factor-\u03b2 and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res. 67, 75\u201384 (2007).","journal-title":"Cancer Res."},{"key":"11533_CR33","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1101\/gad.1388806","volume":"20","author":"H Jian","year":"2006","unstructured":"Jian, H. et al. Smad3-dependent nuclear translocation of \u03b2-catenin is required for TGF-\u03b21-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 20, 666\u2013674 (2006).","journal-title":"Genes Dev."},{"key":"11533_CR34","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/sj.emboj.7601057","volume":"25","author":"W Liu","year":"2006","unstructured":"Liu, W. et al. Axin is a scaffold protein in TGF-\u03b2 signaling that promotes degradation of Smad7 by Arkadia. EMBO J. 25, 1646\u20131658 (2006).","journal-title":"EMBO J."},{"key":"11533_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrg2041","volume":"8","author":"C Lanctot","year":"2007","unstructured":"Lanctot, C., Cheutin, T., Cremer, M., Cavalli, G. & Cremer, T. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat. Rev. Genet. 8, 104\u2013115 (2007).","journal-title":"Nat. Rev. Genet."},{"key":"11533_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.291.5505.843","volume":"291","author":"T Misteli","year":"2001","unstructured":"Misteli, T. Protein dynamics: implications for nuclear architecture and gene expression. Science 291, 843\u2013847 (2001).","journal-title":"Science"},{"key":"11533_CR37","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/nature03043","volume":"431","author":"CM Shachaf","year":"2004","unstructured":"Shachaf, C. M. et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431, 1112\u20131117 (2004).","journal-title":"Nature"},{"key":"11533_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrc3876","volume":"15","author":"T Moroishi","year":"2015","unstructured":"Moroishi, T., Hansen, C. G. & Guan, K. L. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 15, 73\u201379 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"11533_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt.3765","volume":"35","author":"A Khvorova","year":"2017","unstructured":"Khvorova, A. & Watts, J. K. The chemical evolution of oligonucleotide therapies of clinical utility. Nat. Biotechnol. 35, 238\u2013248 (2017).","journal-title":"Nat. Biotechnol."},{"key":"11533_CR40","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1158\/1535-7163.MCT-18-0824","volume":"18","author":"T Harada","year":"2019","unstructured":"Harada, T. et al. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth. Mol. Cancer Ther. 18, 602\u2013612 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"11533_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.30075","volume":"139","author":"K Shinkai","year":"2016","unstructured":"Shinkai, K. et al. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Int. J. Cancer 139, 433\u2013445 (2016).","journal-title":"Int. J. Cancer"},{"key":"11533_CR42","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1038\/onc.2014.402","volume":"34","author":"S Fujii","year":"2015","unstructured":"Fujii, S., Matsumoto, S., Nojima, S., Morii, E. & Kikuchi, A. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Oncogene 34, 4834\u20134844 (2015).","journal-title":"Oncogene"},{"key":"11533_CR43","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1172\/JCI84658","volume":"126","author":"H Kimura","year":"2016","unstructured":"Kimura, H. et al. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression. J. Clin. Investig. 126, 2689\u20132705 (2016).","journal-title":"J. Clin. Investig."},{"key":"11533_CR44","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1128\/MCB.25.20.9063-9072.2005","volume":"25","author":"S Hino","year":"2005","unstructured":"Hino, S., Tanji, C., Nakayama, K. I. & Kikuchi, A. Phosphorylation of \u03b2-catenin by cyclic AMP-dependent protein kinase stabilizes \u03b2-catenin through inhibition of its ubiquitination. Mol. Cell. Biol. 25, 9063\u20139072 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"11533_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/cas.13109","volume":"108","author":"T Harada","year":"2017","unstructured":"Harada, T. et al. Wnt5b-associated exosomes promote cancer cell migration and proliferation. Cancer Sci. 108, 42\u201352 (2017).","journal-title":"Cancer Sci."},{"key":"11533_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/srep10536","volume":"5","author":"A Sato","year":"2015","unstructured":"Sato, A. et al. The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-\u03b3 in colitis. Sci. Rep. 5, 10536 (2015).","journal-title":"Sci. Rep."},{"key":"11533_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0092-8674(84)90457-4","volume":"39","author":"D Kalderon","year":"1984","unstructured":"Kalderon, D., Roberts, B. L., Richardson, W. D. & Smith, A. E. A short amino acid sequence able to specify nuclear location. Cell 39, 499\u2013509 (1984).","journal-title":"Cell"},{"key":"11533_CR48","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","volume":"72","author":"H Miyoshi","year":"1998","unstructured":"Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H. & Verma, I. M. Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150\u20138157 (1998).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11533-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11533-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:58:11Z","timestamp":1671238691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11533-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["11533"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-11533-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,28]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3882"}}